Halozyme Therapeutics
HALO
#2402
Rank
NZ$12.89 B
Marketcap
NZ$109.62
Share price
0.60%
Change (1 day)
32.25%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.87 Billion

According to Halozyme Therapeutics's latest financial reports the company has NZ$0.87 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.64 B386.78%
2023-12-31$NZ$0.13 B-50.45%
2022-12-31$NZ$0.26 B-7.25%
2021-12-31$NZ$0.28 B37.74%
2020-12-31$NZ$0.20 B53.64%
2019-12-31$NZ$0.13 B-63.28%
2018-12-31$NZ$0.37 B26.47%
2017-12-31$NZ$0.29 B-725.68%
2016-12-31$-NZ$46.9 Million-174.64%
2015-12-31$NZ$62.82 M19.04%
2014-12-31$NZ$52.77 M-316.96%
2013-12-31$-NZ$24.33 Million-140.96%
2012-12-31$NZ$59.38 M325.21%
2011-12-31$NZ$13.96 M-47.06%
2010-12-31$NZ$26.37 M177.55%
2009-12-31$NZ$9.5 M-64.14%
2008-12-31$NZ$26.5 M-64.86%
2007-12-31$NZ$75.41 M130.19%
2006-12-31$NZ$32.76 M22.99%
2005-12-31$NZ$26.63 M28.22%
2004-12-31$NZ$20.77 M3512.82%
2003-12-31$NZ$0.57 M-179.29%
2002-12-31$-NZ$0.73 Million-1418.68%
2001-12-31$NZ$0.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
MannKind Corp
MNKD
-NZ$77.12 Million-108.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B 4,633.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$12.48 B 1,331.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 18,374.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.38 B 17,025.35%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$137.22 B 15,632.22%๐Ÿ‡บ๐Ÿ‡ธ USA